Profiel
John Waterfall is a Director of Xenova Group Plc.
He joined Xenova Group Plc as Research and Development Director in May 1999.
He was Divisional Vice President of Global Project Management for Hoffmann-La Roche, Inc. He was the Head of Cardiovascular and Autonomic Pharmacology for Wyeth Laboratories.
He received a PhD from the Institute of Cancer Research and a Bachelor's degree from the University of Nottingham.
Eerdere bekende functies van John Waterfall
| Bedrijven | Functie | Einde |
|---|---|---|
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Corporate Officer/Principal | 09-07-2007 |
Opleiding van John Waterfall
| The University of Nottingham | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
